Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Management

<< Previous

Bullboard Posts

Next >>

Comment by tylerreddickon Mar 19, 2024 6:01pm

78 Views

Post# 35941725

RE:RE:Management

forhandlaren wrote: Meet with Howard at the AGM and help him to save the company by stepping down as CEO in order to increase the share price and close the private placement.

If they don't manage to secure necessary cashflow the company will default. Howard might be too proud though and prefer to be remembered at the stubborn captain that killed the company rather than make a change and save it.

I find it curious that no one steps up to support the share price. Insiders can't do it because of the outstanding financing, but anyone close to them certainly could.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant